SLRX
Salarius Pharmaceuticals, Inc.
Latest Form 4:Sale$17byHANISH ARNOLD C (Director) · filed Jan 2, 2026
Salarius Pharmaceuticals, Inc. (SLRX) has 3 SEC Form 4 filings (4 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jan 2, 2026.
- Industry:Biotechnology
- CEO:Frederick E. Pierce
- Employees:2
- HQ:Houston, TX, US
- IPO:2015-01-29
Insider Buying
$20K
reported purchases (SEC code P)
Insider Selling
$17
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
| Source | ||||||
|---|---|---|---|---|---|---|
| Director | Sale | 27 | $17 | Jan 2 | SEC ↗ | |
HANISH ARNOLD CFirst filing | Director | Purchase | 5,000 | $4K | Nov 24 | SEC ↗ |
Rosenblum Mark JFirst filing | Exec VP Finance, CFO | Purchase | 20,000 | $16K | Nov 20 | SEC ↗ |